Skip to Main content Skip to Navigation
New interface
Journal articles

Industrialiser les médicaments ayurvédiques : les voies indiennes de l'innovation pharmaceutique

Abstract : Long confined to Europe and the United States, pharmaceutical innovation is now center stage in India. This article explores innovation in the Ayurvedic industry as a form of alternative modernity. This alternative industry contrasts in key ways with the molecular paradigm that has dominated pharmaceutical research in the North since the mid-twentieth century. India offers other ways to pharmaceutical innovation based on forms of knowledge essentially foreign to pharmaceutical screening and biotechnology. The industry reinvents its Ayurvedic remedies by borrowing from various orders of medical thought and from techniques that belong to modern Galenics, biomedicine, and Indian traditions. This model represents an innovative mode of knowledge production and accounts for the introduction of an independent pharmacy in an arena formerly primarily medical. Essentially based on reverse engineering, this innovation regime involves the reformulation and simplification of Ayurvedic preparations in order to create new “traditional” medicines for the biomedically-defined disorders of an international clientele. This article opens avenues for the study of these new drugs, the construction of a global market, and of an economy of property rights without the need for pharmaceutical patents.
Document type :
Journal articles
Complete list of metadata

https://hal-cnrs.archives-ouvertes.fr/hal-03478557
Contributor : Colette ORANGE Connect in order to contact the contributor
Submitted on : Tuesday, December 14, 2021 - 8:39:10 AM
Last modification on : Tuesday, January 25, 2022 - 11:32:05 AM

Identifiers

Citation

Laurent Pordié, Jean-Paul Gaudillière. Industrialiser les médicaments ayurvédiques : les voies indiennes de l'innovation pharmaceutique. Autrepart - Revue de sciences sociales au Sud, 2013, 63 (1), pp.123-143. ⟨10.3917/autr.063.0123⟩. ⟨hal-03478557⟩

Share

Metrics

Record views

22